Preclinical trials face several challenges. One major challenge is the translation of findings from animal models to human patients, as results may not always be predictive of human responses. Another challenge is the heterogeneity of cancer, which can make it difficult to identify a universally effective treatment. Additionally, there are ethical considerations and regulatory requirements that must be met to ensure the welfare of animal subjects.
